Sandrine Eimer
Overview
Explore the profile of Sandrine Eimer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
471
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laine G, Baldi I, Jecko V, Betancourt Z, Bertaud E, Huchet A, et al.
Neuroepidemiology
. 2022 Mar;
56(4):250-260.
PMID: 35320802
Background: The Gironde Central Nervous System (CNS) Tumor Registry, in collaboration with the French National Cancer Institute, is the largest population-based registry focused exclusively on primary CNS tumors in France...
2.
Lasolle H, Ferriere A, Vasiljevic A, Eimer S, Nunes M, Tabarin A
Endocr Connect
. 2019 Sep;
8(10):1383-1394.
PMID: 31518993
Purpose: Little data are available regarding the safety and efficacy of switching to Pasireotide-LAR monotherapy in acromegaly patients with partial resistance to first-generation somatostatin agonists (1gSRL) who require combination treatment...
3.
Fernandez P, Zanotti-Fregonara P, Eimer S, Gimbert E, Monteil P, Penchet G, et al.
Nucl Med Commun
. 2019 Aug;
40(10):1066-1071.
PMID: 31469809
Objective: 3'-Deoxy-3'-[18F] fluorothymidine (18F-FLT) is a marker of cell proliferation and displays a high tumor-to-background ratio in brain tumor lesions. We determined whether combining 18F-FLT PET and MRI study improves...
4.
Le Loarer F, Laffont S, Lesluyes T, Tirode F, Antonescu C, Baglin A, et al.
Am J Surg Pathol
. 2019 Mar;
43(6):747-754.
PMID: 30829729
Biphenotypic sinonasal sarcoma (BSNS) is a locally aggressive tumor occurring in the sinonasal region. It harbors both myogenic and neural differentiation and is characterized by PAX3 rearrangement with MAML3 as...
5.
Bruno A, Labreche K, Daniau M, Boisselier B, Gauchotte G, Royer-Perron L, et al.
Neuro Oncol
. 2018 Feb;
20(8):1092-1100.
PMID: 29432597
Background: Primary central nervous system lymphoma (PCNSL) represents a particular entity within non-Hodgkin lymphomas and is associated with poor outcome. The present study addresses the potential clinical relevance of chimeric...
6.
Champeaux C, Jecko V, Eimer S, Penchet G
J Korean Neurosurg Soc
. 2016 Jul;
59(4):414-9.
PMID: 27446526
A 35 years old woman presented with an acute meningeal syndrome following an intra ventricular haemorrhage without subarachnoid haemorrhage. The angiography demonstrated a 6 mm partially thrombosed saccular aneurysm at...
7.
Figarella-Branger D, Mokhtari K, Dehais C, Carpentier C, Colin C, Jouvet A, et al.
Neuro Oncol
. 2016 May;
18(6):888-90.
PMID: 27175000
No abstract available.
8.
Bruno A, Alentorn A, Daniau M, Labussiere M, Rahimian A, Tabouret E, et al.
Acta Neuropathol
. 2015 Jul;
130(3):439-40.
PMID: 26195323
No abstract available.
9.
Wehbe K, Forfar I, Eimer S, Cinque G
Anal Bioanal Chem
. 2015 Jul;
407(24):7295-305.
PMID: 26168973
Gliomas are brain tumours classified into four grades with increasing malignancy from I to IV. The development and the progression of malignant glioma largely depend on the tumour vascularization. Due...
10.
Puccetti P, Fallarino F, Italiano A, Soubeyran I, MacGrogan G, Debled M, et al.
PLoS One
. 2015 Apr;
10(4):e0122046.
PMID: 25881064
Tumor immune escape mechanisms are being regarded as suitable targets for tumor therapy. Among these, tryptophan catabolism plays a central role in creating an immunosuppressive environment, leading to tolerance to...